CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
CARDINAL HEALTH INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 11, 2026
$252.65−1.41 (-0.55%)
Close on Oct 19, 2026
- Market cap
- $59.12B
- P/E (TTM)
- 34.9
- Dividend yield
- 0.81%
CARDINAL HEALTH INC revenue by segment
By business segment
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $58.85B | $56.11B | $60.67B | $59.21B | $55.37B | $50.43B | $50.85B | $47.99B | $55.61B | $50.62B | $53.20B | $50.59B | 92.4% | +6.3% |
| GMPD | $3.13B | $3.15B | $3.26B | $3.18B | $3.20B | $3.16B | $3.15B | $3.12B | $3.11B | $3.11B | $3.13B | $3.03B | 4.9% | -2.2% |
| Other Operating Segment | $1.72B | $1.71B | $1.72B | $1.64B | $1.61B | $1.30B | $1.28B | $1.19B | $1.17B | $1.15B | $1.14B | $1.05B | 2.7% | +7.0% |
| Pharmaceutical | – | – | – | – | – | – | – | – | – | – | $53.52B | $51.01B | – | – |
| Medical | – | – | – | – | – | – | – | – | – | – | $3.93B | $3.76B | – | – |
| Operating income | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $645.00M | $784.00M | $687.00M | $667.00M | $535.00M | $662.00M | $531.00M | $530.00M | $482.00M | $582.00M | $495.00M | $456.00M | +20.6% |
| Other Operating Segment | $183.00M | $179.00M | $179.00M | $166.00M | $160.00M | $134.00M | $118.00M | $104.00M | $111.00M | $110.00M | $106.00M | $96.00M | +14.4% |
| GMPD | $150.00M | $25.00M | $37.00M | $46.00M | $70.00M | $39.00M | $18.00M | $8.00M | $47.00M | $22.00M | $11.00M | $12.00M | +114.3% |
| Pharmaceutical | – | – | – | – | – | – | – | – | – | – | $518.00M | $507.00M | – |
| Medical | – | – | – | – | – | – | – | – | – | – | $71.00M | $71.00M | – |
By product or service
By region
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $63.27B | $60.54B | $65.22B | $63.61B | $59.75B | $54.50B | $54.86B | $51.89B | $59.45B | $54.46B | $57.05B | $54.27B | 99.4% | +5.9% |
| Non-US [Member] | $428.00M | $423.00M | $435.00M | $419.00M | $434.00M | $399.00M | $428.00M | $408.00M | $440.00M | $425.00M | $415.00M | $401.00M | 0.7% | -1.4% |
From the segment and revenue-disaggregation notes of Cardinal Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.